close

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

May 22, 2025 at 21:01 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Media Contact

Naomi Goumillout

Agilent Technologies

+1.978.314.1862

naomi.goumillout@agilent.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

CoreWeave's Backlog Is Surging—Can the Stock Follow? ↗

Today 10:50 EST

Via MarketBeat

What Bit Digital (BTBT) Said on Its Q3 Earnings Call ↗

Today 10:15 EST

Via MarketBeat

AIRO Group Q3 Earnings Call Highlights ↗

Today 10:15 EST

Via MarketBeat

Community Health Systems Sees Surgery Delays Stretching Into Next Year as Costs Squeeze Patients ↗

Today 10:15 EST

Via MarketBeat

What MLP (MLP) Said on Its Q3 Earnings Call ↗

Today 10:15 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	269.32	+3.15 (1.18%)
AAPL	357.60	+1.97 (0.55%)
AMD	570.26	+17.36 (3.14%)
BAC	50.56	-0.11 (-0.21%)
GOOG	292.86	+2.23 (0.77%)
META	623.70	-5.07 (-0.81%)
MSFT	525.67	+4.54 (0.87%)
NVDA	164.73	-9.00 (-5.18%)
ORCL	126.44	-1.94 (-1.51%)
TSLA	390.38	-0.46 (-0.12%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.

Subscribe Today